tirzepatide trump President Donald announced Thursday a deal with drugmakers Novo Nordisk and Eli Lilly to lower the cost of the GLP-1 weight-loss drugs Wegovy and Zepbound. The deal will expand access for President Trump announced that Medicare

Oral GLP-1 Medications: Orforglipron and Beyond The next frontier is oral GLP-1 medications like Orforglipron, developed by Eli Lilly

[Crossref] 5

The combination of proven lipid-lowering therapy with the metabolic benefits of GLP-1 receptor agonists may provide additive cardiovascular protection

Participants and investigators will remain blinded to treatment assignment throughout the trial period (main and extension phases)

While each peptide has an independent body of preclinical literature, no published peer-reviewed study has examined this specific combination, and the theoretical synergy between their complementary mechanisms remains unvalidated by controlled experimental evidence

Cancellation & Refund Policy Sheds cancellation policy is considered strict